Zobrazeno 1 - 10
of 33 943
pro vyhledávání: '"large B‐cell lymphoma"'
Autor:
Saskia Räuber, Andreas Schulte-Mecklenbeck, Alice Willison, Ramona Hagler, Marius Jonas, Duygu Pul, Lars Masanneck, Christina B. Schroeter, Kristin S. Golombeck, Stefanie Lichtenberg, Christine Strippel, Marco Gallus, Andre Dik, Ruth Kerkhoff, Sumanta Barman, Katharina J. Weber, Stjepana Kovac, Melanie Korsen, Marc Pawlitzki, Norbert Goebels, Tobias Ruck, Catharina C. Gross, Werner Paulus, Guido Reifenberger, Michael Hanke, Oliver Grauer, Marion Rapp, Michael Sabel, Heinz Wiendl, Sven G. Meuth, Nico Melzer
Publikováno v:
Journal of Neuroinflammation, Vol 21, Iss 1, Pp 1-21 (2024)
Abstract Background Immune dysregulation is a hallmark of autoimmune diseases of the central nervous system (CNS), characterized by an excessive immune response, and primary CNS tumors (pCNS-tumors) showing a highly immunosuppressive parenchymal micr
Externí odkaz:
https://doaj.org/article/848c9d49598a4962b05d92211b97ff55
Autor:
Nelly O. Elshafie, Michael Gribskov, Nathanael I. Lichti, Ekramy E. Sayedahmed, Michael O. Childress, Andrea Pires dos Santos
Publikováno v:
FEBS Open Bio, Vol 14, Iss 11, Pp 1899-1913 (2024)
Diffuse large B‐cell lymphoma (DLBCL) is the most prevalent subtype of non‐Hodgkin lymphoma (NHL) in domestic dogs, with many similarities to its human counterpart. The progression of the disease is rapid, and treatment must be initiated early to
Externí odkaz:
https://doaj.org/article/9a51b6ad30a04c1087d67b5b84f7f347
Autor:
Kristyna Kupcova, Jana Senavova, Filip Jura, Vaclav Herman, Anezka Rajmonova, Mariana Pacheco-Blanco, Tereza Chrbolkova, Iva Hamova, R. Eric Davis, Ondrej Havranek
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-6 (2024)
Abstract The phosphatidylinositol 3‑kinase/protein kinase B (PI3K/AKT) signaling pathway is critically active in many cell types, both normal and neoplastic. Many small-molecule inhibitors targeting different levels of the PI3K/AKT pathway have bee
Externí odkaz:
https://doaj.org/article/a0c2c0e551524346977216024eee5ee7
Autor:
Gloria Iacoboni, Víctor Navarro, Pierre Sesques, Kai Rejeski, Mariana Bastos-Oreiro, Fabio Serpenti, Ana Africa Martin Lopez, Josu Iraola-Truchuelo, Javier Delgado, Ariadna Perez, Manuel Guerreiro, Ana Carolina Caballero, Nuria Martinez-Cibrian, Hugo Luzardo Henriquez, Jose Maria Sanchez Pina, Juan-Manuel Sancho, Hervé Ghesquieres, Alberto Mussetti, Lucia Lopez Corral, Rafael Hernani, Juan Luis Reguera, Anna Sureda, Francesc Bosch, Alejandro Martin Garcia-Sancho, Mi Kwon, Marion Subklewe, Andrea Kuhnl, Emmanuel Bachy, Pere Barba, Guillermo Villacampa, Pau Abrisqueta
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-10 (2024)
Abstract Chimeric antigen receptor (CAR) T-cell therapy fails to achieve durable responses in over 60% of relapsed/refractory (R/R) large B-cell lymphoma (LBCL) patients in the third or later line setting. After CAR-T failure, survival outcomes are h
Externí odkaz:
https://doaj.org/article/7a33c510abd6496482324ad69e68ca9f
Publikováno v:
Infectious Agents and Cancer, Vol 19, Iss 1, Pp 1-11 (2024)
Abstract Objective Hepatitis B virus (HBV) infection is associated with the incidence and prognosis of diffuse large B-cell lymphoma (DLBCL), and previous studies differ in terms of clinical characteristics and prognostic factors. In this study, we e
Externí odkaz:
https://doaj.org/article/800ead757104420e9a2db36117373428
Autor:
Naoki Watanabe, Sakiko Harada, Shoko Sato, Yasutaka Fukuda, Yuina Tanaka, Kensuke Yanashima, Eriko Sato, Daisuke Taniguchi, Yuji Tomizawa, Nobutaka Hattori, Miki Ando
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1201-1207 (2024)
Introduction: Neurolymphomatosis (NL) is a rare condition characterized by the infiltration of malignant lymphoma cells into the peripheral nervous system. The optimal treatment for NL remains unclear, and patients with secondary NL have a poor progn
Externí odkaz:
https://doaj.org/article/8216429e600b4fef9801f8521bfe32d5
Autor:
Nor Adzimah Johdi, Amanda Seng, Wei-Kang Lee, Hanif Zulkhairi Mohamad Said, Wan Fariza Wan Jamaluddin
Publikováno v:
Iranian Journal of Medical Sciences, Vol 49, Iss 10, Pp 652-660 (2024)
Background: Diffuse large B-cell lymphoma (DLBCL) is globally recognized as the most prevalent and aggressive subtype of non-Hodgkin lymphoma. While conventional treatments are effective initially, the disease can become resistant or relapse over tim
Externí odkaz:
https://doaj.org/article/0a9aa95fff854ee1b21d4818c175d38c
Publikováno v:
Вестник рентгенологии и радиологии, Vol 105, Iss 2, Pp 87-92 (2024)
The article presents a detailed analysis of clinical observation of primary diffuse large B-cell lymphoma of the adrenal glands, a rare disease affecting less than 1% of patients with non-Hodgkin’s lymphomas. It describes the case of a 46-year-old
Externí odkaz:
https://doaj.org/article/72981994df894f43a888577e0d8b63f1
Autor:
ChiIeng Tou, LinFeng Ma
Publikováno v:
Radiology Case Reports, Vol 19, Iss 10, Pp 4497-4503 (2024)
Primary mediastinal large B-cell lymphoma (PMBCL) is a specific subtype of diffuse large B-cell lymphoma (DLBCL), which occurs more frequently in young women. PMBCL is an uncommon kind of cancer. R-EPOCH is a common therapeutic regimen that is suitab
Externí odkaz:
https://doaj.org/article/8dfe0799e24e451b96a2b0edbb0e4c4a
Autor:
Priya Das, MBBS, Kaustubh Gupta, MBBS, MD, Gaurav Raj, MBBS, MD, Vini Tandon, MBBS, MD, Namrata Punit Awasthi, MBBS, MD, Yatendra Parashar, MBBS, MD
Publikováno v:
Radiology Case Reports, Vol 19, Iss 10, Pp 4440-4444 (2024)
Non-Hodgkin's lymphoma are neoplasms derived from T cells and B cells and their precursors in the lymphoid system with higher susceptibility in involvement of extra-nodal sites. Predominant ureteric involvement is an unusual presentation. We present
Externí odkaz:
https://doaj.org/article/ea090ad211c2476ab03d3239424fa979